Vera Therapeutics (VERA) Enterprise Value (2020 - 2026)
Vera Therapeutics (VERA) posted Enterprise Value of -$596.8 million for Q1 2026, up 16.49% on a QoQ basis from -$714.6 million in Q4 2025, and down 1.17% year-over-year from -$603.9 million in Q1 2025.
Vera Therapeutics (VERA) Enterprise Value (2020 - 2026) Analysis & Trends
Vera Therapeutics' Enterprise Value history runs 7 years deep, the most recent figure standing at -$596.8 million for Q1 2026.
- Quarterly Enterprise Value fell 1.17% year-over-year to -$596.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$596.8 million (down 1.17% YoY) and the FY2025 annual result came in at -$714.6 million, down 11.51% from the prior year.
- Enterprise Value was -$596.8 million for Q1 2026 at Vera Therapeutics, up from -$714.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$114.4 million in Q3 2022 and bottomed at -$714.6 million in Q4 2025.
- A 5-year average of -$349.9 million and a median of -$353.3 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value slumped 298.75% — and 2026, when it fell 1.17%.
- Vera Therapeutics' Enterprise Value stood at -$114.7 million in 2022, then tumbled by 40.18% to -$160.7 million in 2023, then slumped by 298.75% to -$640.9 million in 2024, then dropped by 11.51% to -$714.6 million in 2025, then advanced by 16.49% to -$596.8 million in 2026.
- Business Quant data shows VERA's Enterprise Value at -$596.8 million in Q1 2026, -$714.6 million in Q4 2025, and -$497.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Vera Therapeutics | 2.60 Bn | 2.60 Bn | - | -596.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -596.76 Mn |
| Dec 31, 2025 | -714.59 Mn |
| Sep 30, 2025 | -497.39 Mn |
| Jun 30, 2025 | -556.83 Mn |
| Mar 31, 2025 | -589.83 Mn |
| Dec 31, 2024 | -640.85 Mn |
| Sep 30, 2024 | -353.31 Mn |
| Jun 30, 2024 | -384.39 Mn |
| Mar 31, 2024 | -403.66 Mn |
| Dec 31, 2023 | -160.72 Mn |
| Sep 30, 2023 | -159.94 Mn |
| Jun 30, 2023 | -181.02 Mn |
| Mar 31, 2023 | -197.15 Mn |
| Dec 31, 2022 | -114.65 Mn |
| Sep 30, 2022 | -114.42 Mn |
| Jun 30, 2022 | -131.93 Mn |
| Mar 31, 2022 | -150.94 Mn |
| Dec 31, 2021 | -79.67 Mn |
| Sep 30, 2021 | -86.25 Mn |
| Jun 30, 2021 | -91.68 Mn |